Literature DB >> 19754480

Insulin resistance and C-reactive protein in preeclampsia.

Milan Stefanović1, Predrag Vukomanović, Mileva Milosavljević, Ranko Kutlesić, Jasmina Popović, Aleksandra Tubić-Pavlović.   

Abstract

Preeclampsia is referred to as the "disease of the theories" because of the multiple hypotheses proposed to explain is occurrence. Despite considerable research, the causes of preeclampsia remain unclear. Preeclampsia is likely to be multifactorial in origin, and recent research has focused on endothelial dysfunction as a central abnormality in preeclampsia. Insulin resistance and inflammation may contribute to the onset of preeclampsia. They could also be correlated. The aim of the study was to evaluate the presence and relationship between insulin resistance and its markers and C-reactive protein as a marker of inflammation. During their third trimester, 17 preeclamptic women and 20 normotensive controls underwent oral glucose tolerance test, basic biochemical analyses and SHBG. Preeclamptic women were more insulin resistant (p=0,004), and they had higher triglycerides levels (p=0,006), uric acid (p=0,002). However, the study groups did not differ in C-reactive protein (CRP), sex hormone-binding globulin (SHBG), high and low-density lipoproteins (HDL-cholesterol and LDL-cholesterol). In multiple regression analysis only SHBG (p=0,014) and triglycerides (p=0,003) were associated with insulin sensitivity independently of the body mass index (BMI), weight gain, HDL and LDL, and CRP. Preeclampsia is a state of increased insulin resistance, and CRP as the marker of inflammation was not increased in our research, and not associated with established preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754480      PMCID: PMC5632509          DOI: 10.17305/bjbms.2009.2813

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  19 in total

1.  Preeclampsia -- searching for the cause.

Authors:  Caren G Solomon; Ellen W Seely
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Insulin causes endothelial dysfunction in humans: sites and mechanisms.

Authors:  Guido Arcaro; Anna Cretti; Sara Balzano; Alessandro Lechi; Michele Muggeo; Enzo Bonora; Riccardo C Bonadonna
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

Review 3.  Endocrine regulation of metabolic homeostasis during pregnancy.

Authors:  S S Yen
Journal:  Clin Obstet Gynecol       Date:  1973-09       Impact factor: 2.190

4.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

Review 5.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.

Authors:  Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

6.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

7.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  First trimester insulin resistance and subsequent preeclampsia: a prospective study.

Authors:  Myles Wolf; Laura Sandler; Kristine Muñoz; Karen Hsu; Jeffrey L Ecker; Ravi Thadhani
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

9.  Insulin sensitivity in pre-eclampsia.

Authors:  R N Roberts; J E Henriksen; D R Hadden
Journal:  Br J Obstet Gynaecol       Date:  1998-10

10.  Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.

Authors:  M L Tjoa; J M G van Vugt; A T J J Go; M A Blankenstein; C B M Oudejans; I J van Wijk
Journal:  J Reprod Immunol       Date:  2003-06       Impact factor: 4.054

View more
  2 in total

1.  Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Jennifer G Robinson; Kelli K Ryckman
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

2.  Level of High Sensitive C-reactive Protein and Procalcitonin in Pregnant Women with Mild and Severe Preeclampsia.

Authors:  Reihane Jannesari; Elham Kazemi
Journal:  Adv Biomed Res       Date:  2017-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.